[go: up one dir, main page]

GB2155331B - Composition for reducing intraocular pressure - Google Patents

Composition for reducing intraocular pressure

Info

Publication number
GB2155331B
GB2155331B GB08406180A GB8406180A GB2155331B GB 2155331 B GB2155331 B GB 2155331B GB 08406180 A GB08406180 A GB 08406180A GB 8406180 A GB8406180 A GB 8406180A GB 2155331 B GB2155331 B GB 2155331B
Authority
GB
United Kingdom
Prior art keywords
composition
intraocular pressure
reducing intraocular
reducing
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08406180A
Other versions
GB8406180D0 (en
GB2155331A (en
Inventor
Thomas H Maren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Priority to GB08406180A priority Critical patent/GB2155331B/en
Publication of GB8406180D0 publication Critical patent/GB8406180D0/en
Publication of GB2155331A publication Critical patent/GB2155331A/en
Application granted granted Critical
Publication of GB2155331B publication Critical patent/GB2155331B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08406180A 1980-07-09 1984-03-09 Composition for reducing intraocular pressure Expired GB2155331B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08406180A GB2155331B (en) 1980-07-09 1984-03-09 Composition for reducing intraocular pressure

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16722080A 1980-07-09 1980-07-09
GB08406180A GB2155331B (en) 1980-07-09 1984-03-09 Composition for reducing intraocular pressure

Publications (3)

Publication Number Publication Date
GB8406180D0 GB8406180D0 (en) 1984-04-11
GB2155331A GB2155331A (en) 1985-09-25
GB2155331B true GB2155331B (en) 1988-09-01

Family

ID=26287434

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08406180A Expired GB2155331B (en) 1980-07-09 1984-03-09 Composition for reducing intraocular pressure

Country Status (1)

Country Link
GB (1) GB2155331B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US6337340B1 (en) * 1998-08-14 2002-01-08 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033042B1 (en) * 1980-01-28 1984-08-22 Merck & Co. Inc. Ophthalmic inserts for lowering intraocular pressure comprising carbonic anhydrase inhibitors
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
JPH0245604B2 (en) * 1980-07-09 1990-10-11 Yunibaashitei Obu Furorida Za
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure

Also Published As

Publication number Publication date
GB8406180D0 (en) 1984-04-11
GB2155331A (en) 1985-09-25

Similar Documents

Publication Publication Date Title
JPS5714339A (en) Blunt-hook for operation
JPS56150053A (en) Polyisocyanate composition
JPS56152451A (en) Novel composition
AU545004B2 (en) Antigingivites composition
JPS5763339A (en) Sealing composition
JPS57122866A (en) Pennis prosthesis
DE3164692D1 (en) Ultraviolet-transmissible composition
JPS5740518A (en) Self-oxidizable composition
JPS5767051A (en) Hydraulic composition
JPS57212118A (en) Ophthalmic composition
AU544317B2 (en) Elastomeric composition
JPS5784361A (en) Protector for accelometer
JPS5711867A (en) Hydraulic composition
JPS57100949A (en) Hydraulic composition
JPS573839A (en) Composition
JPS5711202A (en) Panty
GB2155331B (en) Composition for reducing intraocular pressure
GB2072020B (en) Hand prosthesis
JPS5771841A (en) Hydraulic composition
JPS57126546A (en) Constant low pressure caburator
JPS57112498A (en) Size composition for papermaking
JPS56104746A (en) Heatttransparencyyloosing sealing composition
AU542682B2 (en) Polyether-silicone composition
JPS5759941A (en) Composition
JPS5767512A (en) Ophthalmic composition

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20040308